Amneal And mAbxience Ally On Denosumab In US

Deal Agreed Between Partners On Biosimilar Candidates Referencing Prolia And Xgeva

 
• By David Wallace
  
Amneal HQ building sign
Amneal has added two denosumab biosimilars to its pipeline • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business